… The deployment of cancer therapeutic agents that target specific molecular pathways has
been the hallmark of drug development in oncology over the past decade 1 . In a limited …

… in specific tissue types as well as pathologic characterization may prove to be a timely
tool to help optimize the effectiveness of this class of potential cancer therapeutic agents. …

… cancer therapeutic agents and have progressed to phase I or phase II trials in treatment of
multiple types of cancers… molecules including some cancer therapeutic drugs. Conventional …

… and differences between the physiologic state of pregnancy and the pathologic state of
cancer could lead to identification of new potential targets for cancer therapeutic agents. …

… 17], a brief summary of recent progress of cancer therapy is useful for junior researchers to …
cancer therapy performance of various inorganic nanoparticles. In this review, cancer therapy …

… as a strategy to circumvent acquired resistance to antiâ•’cancer therapeutic agents … Thus
even if other major problems in cancer therapy can be overcome such as improved drug/agent …

… in cancer and cancer therapy. In order to define the role of mitochondria in cancer therapy, we
… line completely lacking mitDNA to different anticancer agents. Our results demonstrate that …

… in cancer cells under therapeutic stress, and induction of autophagy is associated with
chemoresistance of cancer cells to chemotherapeutic agents. … cells to cancer therapeutic agents, …

… recent advances in lung cancer therapeutics with a specific … agents, immunotherapies,
and antibody drug conjugates for small cell lung cancer (SCLC) and non-small-cell lung cancer …

… as an invaluable source of potential therapeutic agents, and are also are well known to
play essential roles in a variety of human disease treatments, such as in cancer 1. Also, they …